FdaApplication
NDA 017090
Identifiers
- fda_app_no: NDA017090
Properties
| Property | Value |
|---|---|
| applicant_name | SPECGX LLC |
| application_type | NDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOFRANIL-PM | IMIPRAMINE PAMOATE | EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| TOFRANIL-PM | IMIPRAMINE PAMOATE | EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| TOFRANIL-PM | IMIPRAMINE PAMOATE | EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| TOFRANIL-PM | IMIPRAMINE PAMOATE | EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
4 products